Shaare Zedek 2018 – End of Year Summary

2018 was another year of extensive service and contribution for Shaare Zedek Medical Center. The trends of growth and innovation we have seen over the past decades continue to flourish with unprecedented expansion.
 



 

Shaare Zedek is the hospital in Israel that has grown the most in the last 10 years. This was particularly evident this year with significant increases in the number of surgeries, the number of referrals to ER and the number of treatments provided in the various clinics and institutes.

In 2018, 92,500 people were treated in ER (adults). We saw 36,200 children in Pediatric ER and our staff in Obstetrics ER cared for 31,500 women. All in all, more than 160,000 referrals to our emergency rooms!

Approximately 35,700 operations were performed in the hospital.

707,000 people visited the various institutes and out-patient clinics, and more than 92,000 patients were hospitalized (over 391,000 hospitalization days).

During 2018, approximately 22,749 babies were born in our two campuses – Shaare Zedek and Bikur Holim – to 22,397 mothers. This is an unprecedented number in Israel and in the western world as well.

The new Brain Unit expanded its activities in 2018, with 308 head surgeries and 229 brain catheters. In addition, about 1,000 people were referred to ER with suspected strokes or TIAs. 130 of them were treated with TPA (Tissue Plasminogen Activator, a substance administered intravenously that dissolves the blood clots causing the stroke). 

The Cardiology Department at Shaare Zedek was significantly upgraded and now serves as a Cardiology-Surgical Center, headed by Prof. Michael Glickson. Within this new framework there has been growth in all areas, including heart surgeries and cardiac arrhythmia (irregular heartbeats) treatment; an improvement in the imaging department and an increase in the number of patients hospitalized in the largest Cardiology department in Israel. 

The Institute for the Rehabilitation and Prevention of Cardiac Diseases, an integral part pf the new unit, moved to its new premises. A new Heart Failure Clinic was dedicated and at the end of 2018 the first artificial heart transplant was performed on a patient suffering from heart failure.

The opening of new institutes did not stop with the Cardiology Unit. This year, Shaare Zedek opened two new centers designed to serve the Jerusalem public: The Talia Center, in memory of the late Talia Belilius, which accompanies young women with breast cancer, offering them an additional support system. And the Vision Institute, a multi-disciplinary center, offering laser treatment for removing glasses and a wide variety of possibilities for advanced Ophthalmology treatments.

Shaare Zedek continues to equip itself with the most advanced technology. This year we bought an innovative Force CT machine, which enables accurate and fast diagnosis of cardiological problems. This device joins other breakthrough technology in the hospital's Integrated Heart Center.

For the Ophthalmology Department we bought some of the most advanced equipment in the world, including a laser system, which allows for fast and accurate diagnosis of refraction problems and an OCT device which can identify hidden retinal layers and deliver better surgical results.

Another innovation this year is the new commercial area for the benefit of patients and their families. It contains many useful stores frequented by thousands of daily visitors.

Always looking forward, Shaare Zedek has begun work on a new Radiotherapy Center, due to open in 2021, and an underground parking lot slated to alleviate the current congestion.

"We are seeing that the trust Jerusalem residents have in Share Zedek is growing. This is corroborated by the numbers that just grow every year, both in terms of the service supply and the sheer number of patients that come through our doors. The public's satisfaction with our services indicates that we are on the right path," says hospital Director-General Prof. Jonatan Halevy, who this year will be ending his 31-year tenure in the position.